A Pilot Phase 2a Blinded, Placebo Controlled, Multicenter Parallel Group, Dose Ranging Study to Evaluate the Safety and Preliminary Efficacy of AZX100 Drug Product Following Excision of Keloids
Latest Information Update: 20 May 2014
At a glance
- Drugs AZX 100 (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Capstone Therapeutics
- 20 May 2014 New trial record